Lecturer notes for metabolic diseases in Cattle.which is benificial for student of BVSc& AH/DVM and MVsc student. It is My first presentation need your feedback for more presentation like this.
Lecturer notes for metabolic diseases in Cattle.which is benificial for student of BVSc& AH/DVM and MVsc student. It is My first presentation need your feedback for more presentation like this.
A Broad overview for management of PEM. Very important topic for MBBS Students. Seminars ,Lectures and exam preparation can be done using my presentaion. Helpful for CMC Vellore Seminars
Hyperketonemia Treatment at the Individual Cow and Herd LevelDAIReXNET
Dr. Jessica McArt presented this material for a DAIReXNET webinar on January 19, 2016. To see more about this and other webinars, please visit our archived webinar page at http://bit.ly/1wb83YV
describes the sources of lipids. enzymes and stages of digestion in detail. absorption form , transport form and disorders of digestion & absorption included.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
More Related Content
Similar to bovine ketosis-3.pptx gives an overall view about Bovine ketosis
A Broad overview for management of PEM. Very important topic for MBBS Students. Seminars ,Lectures and exam preparation can be done using my presentaion. Helpful for CMC Vellore Seminars
Hyperketonemia Treatment at the Individual Cow and Herd LevelDAIReXNET
Dr. Jessica McArt presented this material for a DAIReXNET webinar on January 19, 2016. To see more about this and other webinars, please visit our archived webinar page at http://bit.ly/1wb83YV
describes the sources of lipids. enzymes and stages of digestion in detail. absorption form , transport form and disorders of digestion & absorption included.
Similar to bovine ketosis-3.pptx gives an overall view about Bovine ketosis (20)
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
2. INTRODUCTION
● Also called Acetonemia, Ketonemia.
● It is a metabolic disease 🡪 lactating dairy cows.
● Weight loss, pica, inappetance, decreased milk production, and neurologic
abnormalities.
● Usually occur during the first 6 weeks of lactation.
● Highest during the third and fourth week of lactation in closely confined.
3. ETIOLOGY
▪ Result of a negative energy balance after parturition.
▪ The cow is unable to eat or assimilate enough nutrients to meet her energy
needs for maintenance and milk production.
▪ Blood glucose levels drop 🡪 Hypoglycemia
▪ Predisposing factors 🡪 retained fetal membranes, metritis, mastitis, displaced
abomasum, fatty livers, environmental stresses, faulty nutrition, and
mismanagement.
4. PATHOPHYSIOLOGY
Low CHO diet,
under nutrition,
starvation
Excess feeding of
silage or protein
rich diets
Heavy milk
production
↓ Propionate formation, ↑ butyrate production,
↑ glucose requirement
↓ Oxaloacetate
production
Hypoglycaemia
Hyglycaemic
encephalopathy
Nervous
signs
Mobilisation of fat
Fats 🡪 FFA + glycerol
Loss of body
weight
Propionate
Glucose
TCA cycle
5. Production of ketone
bodies
Fatty acids 🡪 acetyl COA
Acetoacetyl
COA
Ketone bodies viz;
Acetoacetate
Beta-hydroxy butyrate
Acetone
KETOSIS
Nervous signs;
Isopropyl alcohol
hypoglycaemia
Acidosis
Acetoacetate &
acetone are toxic
6. CLINICAL FINDINGS
▪ Initial signs - slight decrease in
feed intake, drop in milk
production, lethargy, and firm
mucus-covered stools.
▪ Pica is seen, refuse concentrates
🡪 feeds on coarse hay, straw🡪
Selective feeding.
▪ Depression deepen, humpbacked
posture 🡪 due to loss of
subcutaneous fat.
7. CLINICAL KETOSIS
TWO FORMS
DIGESTIVE/ WASTING FORM NERVOUS FORM
Common form Aimless wandering
Selective feeding Staggering gait
Emaciation Circling movement
Faeces are dry, firm & covered with mucus Licking of inanimate objects
Ruminal motility reduced Chewing movements,
Sweetish smell in breath, milk, urine Hyperaesthesia
Temp, Pulse & RR are normal Tremor, convulsions
8. SUB-CLINICAL KETOSIS
● Occurs in high yielding cattle.
● Excessive production of aceto-acetic acid in mammary glands.
● Mild drop in milk production.
● Reduced fertility 🡪
⬇️ Steroid hormones
Licking behaviour
10. NECROPSY FINDINGS
● Non specific
● Yellowish friable enlarged liver
● Enlargement of adrenal cortex
● Fatty changes in kidney and heart.
11. DIAGNOSIS
▪ History 🡪 recent calving, not feeding CHO, feeding high protein diet, high milk production.
▪ Clinical signs 🡪 Acetone odour from breath, urine, or milk.
▪ Clinical pathology 🡪 hypoglycemia, ketonemia, ketouria etc.
▪ Rothera’s test for urine, milk
▪ Dipstick test for urine & milk.
▪ Cowside test 🡪 Beta Hydroxybutyrate
▪ Hematology 🡪 neutropenia(10%), lymphocytosis(60-80%), eosinophilia(15-40%)
12.
13. DIFFERENTIAL DIAGNOSIS
DISEASES DIFFERENTIAL SIGN
TRP Recurrent bloat, pain, x-ray
Vagus Indigestion Papple shaped abdomen
Metritis Purulent vaginal discharge
Surra Org. in blood smear
Theileriosis Swollen lymph nodes, tick infestation
Diabetes mellitis Response to insulin
Tetanus Signs of tetany, no response to glucose
Rabies Dog bite, salivation, bellowing
Lead poisoning Blindness, no response to glucose
Encephalitis/ Meningitis Fever, no response to glucose
15. Replacement therapy:
▪ Glucose therapy 🡪 20% glucose @ 0.5 g/kg for 2-3 days.
▪ This will lead to:
✔Transient hyperglycaemia
✔Increase insulin secretion
✔Decrease Glucagon
✔Decreased NEFA
▪ Propylene glycol – slow but prolong action(225 g, b.i.d. for 2 days, followed by 100 g, daily
for 2 days) or
▪ Other glucose precursors like sodium propionate @ 80g P.O for 3-6 days – slow response.
▪ Oral glucose @ 500g after administering 30g of sod.bicarbonate solution.
16.
17. Hormonal therapy:
▪ Glucocorticosteroids (Dexamethasone @ 0.04mg/kg i.v for 2-3 days.
▪ Insulin as protamine zinc @ 0.5 IU/kg, SC every 24-48 hrs.
▪ Anabolic steroids. (trenbolone acetate or durabolin @ 60-120mg single dose).
▪ Milk production may temporarily decrease after glucocorticoids administration but
increases rapidly after several days.
18. Miscellaneous treatments:
▪ Vitamin B12 (1-2mg/kg) converts propionate to glucose.
▪ Cobalt sulphate @ 100mg/day.
▪ Niacin @ 8g orally for 5-6d – antilipolytic.
▪ Chloral hydrate @ 30g p.o followed by 7g daily for 3-5d – converts
starch into glucose in rumen.
▪ Cysteamine (a biological precursor of coenzyme A) have been used to
treat cases - 750 mg IV for three doses at 1-3 day intervals.
19. PREVENTION
▪ Propylene glycol 🡪 drenched to cattle in early lactation @ 350 to 1000 mL daily for 10
days after calving or 1 L/day oral drench for 9 days prior to parturition has also been
shown efficacious.
▪ Sodium propionate @ 110g daily p.o for 6weeks after calving.
▪ Glycerol in large volume of water and be substituted for propylene glycol at equivalent
dose rates.
▪ Ionophores (Monensin as capsule 25g, 2-4 weeks before calving), alter bacterial flora of
the rumen, leading to ↓ Gram positive bacteria, protozoa, and fungi and ↑ Gram-negative
bacteria.
▪ The net effect 🡪 ↑ propionate production and ↓ acetate and butyrate production.
20. ▪ Feed additives 🡪 propylene glycol, sodium propionate, yeasts, niacin,
choline, etc. have been recommended.
▪ After calving 🡪 concentrate ration @ 1kg per 3kgs of milk.
▪ Cows should be properly conditioned during late lactation and the dry
period.
▪ 2 weeks before parturition, small amount of the concentrate ration then
gradually increased, @ parturition 🡪 1.5 kg/day.
▪ Highly fermentable feeds such as molasses helps to check ketosis.
▪ The ration should contain adequate amounts of essential vitamins and
minerals.
● Give adequate exercise to lactating animals.
● Perform Rothera’s test on urine & milk, regular glucose estimation.
21. ● Reference ;
● Veterinary Medicine by Peter D Constable
● Clinical Veterinary Medicine by Amalendu Chakrabarti
● https://www.msdvetmanual.com/metabolic-disorders/ketosis-in-cattle
THANK YOU!!!
Submitted By :
Ismail K M
VSK 1820
VETERINARY COLLEGE
SHIVAMOGGA
Submitted to :
Department of VCC
VETERINARY COLLEGE
BIDAR